AQTAYO Trademark

Trademark Overview

On Thursday, July 18, 2019, a trademark application was filed for AQTAYO with the United States Patent and Trademark Office. The USPTO has given the AQTAYO trademark a serial number of 88522115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2023. This trademark is owned by Cytokinetics, Inc.. The AQTAYO trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceuticals for the treatment of neurological and musculoskeletal diseases and conditions
aqtayo

General Information

Serial Number88522115
Word MarkAQTAYO
Filing DateThursday, July 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements

Goods and Serviceshuman pharmaceuticals for the treatment of neurological and musculoskeletal diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytokinetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCytokinetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 6, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, October 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 11, 2022SOU EXTENSION 5 GRANTED
Friday, June 3, 2022SOU EXTENSION 5 FILED
Saturday, June 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 3, 2022TEAS EXTENSION RECEIVED
Friday, December 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 22, 2021SOU EXTENSION 4 GRANTED
Wednesday, December 22, 2021SOU EXTENSION 4 FILED
Wednesday, December 22, 2021TEAS EXTENSION RECEIVED
Wednesday, June 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 7, 2021SOU EXTENSION 3 GRANTED
Monday, June 7, 2021SOU EXTENSION 3 FILED
Monday, June 7, 2021TEAS EXTENSION RECEIVED
Friday, December 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 23, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 23, 2020SOU EXTENSION 2 FILED
Wednesday, December 23, 2020TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2020SOU EXTENSION 1 GRANTED
Monday, July 13, 2020SOU EXTENSION 1 FILED
Monday, July 13, 2020TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2019ASSIGNED TO EXAMINER
Friday, July 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 22, 2019NEW APPLICATION ENTERED

Related Keywords

aqtayo diseases conditions musculoskeletal neurological pharmaceuticals treatment human